From: Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study
 | Participants with particular CM syndromes | Participants without particular CM syndromes | ||||
---|---|---|---|---|---|---|
 | N | Reached Predicted | Below Predicted | N | Reached Predicted | Below Predicted |
V1 | 106 | 6 | 100 | 42 | 2 | 40 |
 |  | 5.66% | 94.34% |  | 4.76% | 95.24% |
V2 | 95 | 8 | 87 | 47 | 0 | 47 |
 |  | 8.42% | 91.58% |  | 0% | 100% |
V3 | 90 | 7 | 83 | 43 | 1 | 43 |
 |  | 7.78% | 92.22% |  | 2.27% | 97.73% |
V4 | 89 | 11 | 78 | 45 | 2 | 45 |
 |  | 12.36% | 87.64% |  | 4.26% | 95.74% |
V5 | 80 | 12 | 68 | 42 | 2 | 42 |
 |  | 15% | 85% |  | 4.55% | 95.45% |
V6 | 73 | 12 | 61 | 39 | 4 | 39 |
 |  | 16.44% | 83.56% |  | 9.3% | 90.7% |
V7 | 71 | 13 | 58 | 41 | 3 | 41 |
 |  | 18.31% | 81.69% |  | 6.82% | 93.18% |
V8 | 59 | 10 | 49 | 54 | 4 | 54 |
 |  | 16.95% | 83.05% |  | 6.9% | 93.1% |